Gentel and Thermo Fisher advance new research tool

Madison, Wis. - Gentel Biosciences, a maker of protein-based tools for research, has announced progress on an advanced microarray being developed in collaboration with Thermo Fisher Scientific.

Thermo Fisher, headquartered in Waltham, Mass., and Gentel have completed the first stage of a new patent-pending product that will shift microarrays, or tests, to a new 96-well configuration. The new product will evolve current offerings toward an “ELISA-like” format to increase speed and volume, and enable the automated processing of thousands of samples per day.

ELISAs have long been considered the “gold standard” for protein measurements.

The two companies operate in the same space. Gentel develops of content-based research kits, including a variety of assays in the 96-well format. Thermo Fisher offers a range of microarray chemistry configurations.

Related stories

• Gentel launches cancer-fighting biomarker kit

• Gentel Biosciences hires VP of commercial operations

• Gentel BioSciences appoints Kendrick-Parker to board